CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
followed by maintenance durvalumab and bevacizumab or durvalumab, bevacizumab and olaparib in patients with newly diagnosed advanced ovarian ...
Phase 3
Berlin, Germany and 213 other locations
of olaparib maintenance monotherapy in relapsed high grade serous ovarian cancer (HGSOC) patients (including patients with primary ...
Phase 3
Berlin, Germany and 126 other locations
of Estrogen-receptor (ER) positive high and low grade epithelial ovarian cancer (including fallopian tube and primary peritoneal ca...
Phase 3
Berlin, Germany and 53 other locations
choice of chemotherapy in subjects with platinum-resistant ovarian cancer whose tumors are positive for cyclin E1 protein expressio...
Phase 3
Berlin, Germany and 58 other locations
study is to compare how well Rina-S works against platinum-resistant ovarian cancer compared to chemotherapy drugs that are already ...
Phase 3
Berlin, Germany and 176 other locations
to chemotherapy and in maintenance, in patients with low grade ovarian cancer (including patients with primary peritoneal and / or...
Phase 2
Berlin, Germany and 1 other location
This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with defactinib versus Investigator's choice of treatments (I...
Phase 3
Berlin, Germany and 105 other locations
(PFS) in women with high-grade, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, expressing hig...
Phase 3
Berlin, Germany and 298 other locations
This is a multi-center, prospective, open-label, phase II trial. Patients with suspected advanced ovarian cancer planned to undergo...
Phase 2
Berlin, State of Berlin, Germany and 5 other locations
A Phase 2 study to evaluate the safety and efficacy of TORL-1-23 in patients with advanced ovarian cancer....
Phase 2
Berlin, Berlin, Germany and 65 other locations
Clinical trials
Research sites
Resources
Legal